Transplantation of neural cells for the treatment of ischemic damage due to stroke
Methods for administering neural cells to treat ischemic damage due to stroke are described. The neural cells are preferably porcine neural cells, e.g., embryonic porcine cells, obtained from the striatum of a pig. The neural cells can be modified to be suitable for transplantation into an allogenei...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | JERRI MARTIN JONATHAN DINSMORE |
| description | Methods for administering neural cells to treat ischemic damage due to stroke are described. The neural cells are preferably porcine neural cells, e.g., embryonic porcine cells, obtained from the striatum of a pig. The neural cells can be modified to be suitable for transplantation into an allogeneic or xenogeneic subject, such as a human. For example, the neural cells can be modified such that an antigen (e.g., an MHC class I antigen) on the cell surface which is capable of stimulating an immune response against the cell in an allogeneic or xenogeneic subject is altered (e.g., by contact with an anti-MHC class I antibody, or a fragment or derivative thereof) to inhibit rejection of the cell when introduced into the subject. Another embodiment of the invention features the use of human embryonic striatal cells to treat ischemic damage due to stroke. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU6276899A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU6276899A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU6276899A3</originalsourceid><addsrcrecordid>eNqFyj0KwkAQBtBtLEQ9g3MBG4VoyiCKtcQ6DJtvzeL-sTO5vwr2Vq95S3PvKycpgZOy-pwoO0qYKweyCEHI5Uo6gbSCNSLpd3ixE6K3NHLkJ2icPyGTaM0vrM3CcRBsfq7M9nrpz7cdSh4ghS0SdOgezf7YnNq2O_wfb0nbN1w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Transplantation of neural cells for the treatment of ischemic damage due to stroke</title><source>esp@cenet</source><creator>JERRI MARTIN ; JONATHAN DINSMORE</creator><creatorcontrib>JERRI MARTIN ; JONATHAN DINSMORE</creatorcontrib><description>Methods for administering neural cells to treat ischemic damage due to stroke are described. The neural cells are preferably porcine neural cells, e.g., embryonic porcine cells, obtained from the striatum of a pig. The neural cells can be modified to be suitable for transplantation into an allogeneic or xenogeneic subject, such as a human. For example, the neural cells can be modified such that an antigen (e.g., an MHC class I antigen) on the cell surface which is capable of stimulating an immune response against the cell in an allogeneic or xenogeneic subject is altered (e.g., by contact with an anti-MHC class I antibody, or a fragment or derivative thereof) to inhibit rejection of the cell when introduced into the subject. Another embodiment of the invention features the use of human embryonic striatal cells to treat ischemic damage due to stroke.</description><edition>7</edition><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2000</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20000417&DB=EPODOC&CC=AU&NR=6276899A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20000417&DB=EPODOC&CC=AU&NR=6276899A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JERRI MARTIN</creatorcontrib><creatorcontrib>JONATHAN DINSMORE</creatorcontrib><title>Transplantation of neural cells for the treatment of ischemic damage due to stroke</title><description>Methods for administering neural cells to treat ischemic damage due to stroke are described. The neural cells are preferably porcine neural cells, e.g., embryonic porcine cells, obtained from the striatum of a pig. The neural cells can be modified to be suitable for transplantation into an allogeneic or xenogeneic subject, such as a human. For example, the neural cells can be modified such that an antigen (e.g., an MHC class I antigen) on the cell surface which is capable of stimulating an immune response against the cell in an allogeneic or xenogeneic subject is altered (e.g., by contact with an anti-MHC class I antibody, or a fragment or derivative thereof) to inhibit rejection of the cell when introduced into the subject. Another embodiment of the invention features the use of human embryonic striatal cells to treat ischemic damage due to stroke.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2000</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFyj0KwkAQBtBtLEQ9g3MBG4VoyiCKtcQ6DJtvzeL-sTO5vwr2Vq95S3PvKycpgZOy-pwoO0qYKweyCEHI5Uo6gbSCNSLpd3ixE6K3NHLkJ2icPyGTaM0vrM3CcRBsfq7M9nrpz7cdSh4ghS0SdOgezf7YnNq2O_wfb0nbN1w</recordid><startdate>20000417</startdate><enddate>20000417</enddate><creator>JERRI MARTIN</creator><creator>JONATHAN DINSMORE</creator><scope>EVB</scope></search><sort><creationdate>20000417</creationdate><title>Transplantation of neural cells for the treatment of ischemic damage due to stroke</title><author>JERRI MARTIN ; JONATHAN DINSMORE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU6276899A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2000</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>JERRI MARTIN</creatorcontrib><creatorcontrib>JONATHAN DINSMORE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JERRI MARTIN</au><au>JONATHAN DINSMORE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Transplantation of neural cells for the treatment of ischemic damage due to stroke</title><date>2000-04-17</date><risdate>2000</risdate><abstract>Methods for administering neural cells to treat ischemic damage due to stroke are described. The neural cells are preferably porcine neural cells, e.g., embryonic porcine cells, obtained from the striatum of a pig. The neural cells can be modified to be suitable for transplantation into an allogeneic or xenogeneic subject, such as a human. For example, the neural cells can be modified such that an antigen (e.g., an MHC class I antigen) on the cell surface which is capable of stimulating an immune response against the cell in an allogeneic or xenogeneic subject is altered (e.g., by contact with an anti-MHC class I antibody, or a fragment or derivative thereof) to inhibit rejection of the cell when introduced into the subject. Another embodiment of the invention features the use of human embryonic striatal cells to treat ischemic damage due to stroke.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU6276899A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | Transplantation of neural cells for the treatment of ischemic damage due to stroke |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T01%3A55%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JERRI%20MARTIN&rft.date=2000-04-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU6276899A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |